IDENTIFICATION AND QUANTIFICATION OF VERAPAMIL IN BLOOD AND URINE

Purpose: To adapt and validate an HPLC method for verapamil determination in blood and urine samples. Materials/Methods: Identification of verapamil and its metabolites was made by means of gas-chromatography, using Agilent 7890B/5977A GC-MS system featuring a DB-1701 column. Quantification was don...

Full description

Bibliographic Details
Main Authors: Georgi Bonchev, Snezha Zlateva, Petko Marinov, Ivelina Stefanova
Format: Article
Language:English
Published: Peytchinski Publishing 2020-10-01
Series:Journal of IMAB
Subjects:
Online Access:https://www.journal-imab-bg.org/issues-2020/issue4/2020vol26-issue4-3403-3407.pdf
_version_ 1819172371992412160
author Georgi Bonchev
Snezha Zlateva
Petko Marinov
Ivelina Stefanova
author_facet Georgi Bonchev
Snezha Zlateva
Petko Marinov
Ivelina Stefanova
author_sort Georgi Bonchev
collection DOAJ
description Purpose: To adapt and validate an HPLC method for verapamil determination in blood and urine samples. Materials/Methods: Identification of verapamil and its metabolites was made by means of gas-chromatography, using Agilent 7890B/5977A GC-MS system featuring a DB-1701 column. Quantification was done by means of liquid chromatography on Agilent 1260 series HPLC, equipped with Zorbax Extend-C18 column and both diode-array and fluorescent detection modules. Blood and urine specimens were taken from patients of the Clinic for intensive treatment of acute intoxications and toxicoallergies within the course of their treatment. Results: GC-MS identification of verapamil and its metabolites was carried out after simple liquid-liquid extraction of samples without further chemical derivatization. Adapted HPLC method for quantification require isocratic conditions and mobile phase, consisted of phosphate buffer (pH 2.7; 10 mM) containing 1.5 ml L–1 triethylamine – acetonitrile (70:30, v/v) at 20oC, flow-rate 1.0 mL/min and FLD detection (excitation: 203 nm, emission: 320 nm). The method was demonstrated to be linear within the whole region of interest (4.6-4600 ng mL–1) with excellent accuracy (101.7-102.2%) and inter-day precision (5.81%) as well as good analytical recovery (81.2%) and LOQ (7.0 ng mL–1). Conclusion: A precise and easy to use method for verapamil detection and quantification is developed. The method is applicable as a routine procedure in the Laboratory of analytical toxicology for both diagnosis clarification in cases of acute intoxications and therapeutic drug monitoring.
first_indexed 2024-12-22T20:06:08Z
format Article
id doaj.art-cb8a1ce9478a4223abf5cd4a3d5b0589
institution Directory Open Access Journal
issn 1312-773X
language English
last_indexed 2024-12-22T20:06:08Z
publishDate 2020-10-01
publisher Peytchinski Publishing
record_format Article
series Journal of IMAB
spelling doaj.art-cb8a1ce9478a4223abf5cd4a3d5b05892022-12-21T18:14:07ZengPeytchinski PublishingJournal of IMAB1312-773X2020-10-012643403340710.5272/jimab.2020264.3403IDENTIFICATION AND QUANTIFICATION OF VERAPAMIL IN BLOOD AND URINEGeorgi Bonchev0https://orcid.org/0000-0002-6220-4020Snezha Zlateva1Petko Marinov2Ivelina Stefanova3Clinic for Intensive Treatment of Acute Intoxications and Toxicoallergies, Naval Hospital – Varna, Military Medical Academy, BulgariaClinic for Intensive Treatment of Acute Intoxications and Toxicoallergies, Naval Hospital – Varna, Military Medical Academy, BulgariaClinic for Intensive Treatment of Acute Intoxications and Toxicoallergies, Naval Hospital – Varna, Military Medical Academy, BulgariaClinic for Intensive Treatment of Acute Intoxications and Toxicoallergies, Naval Hospital – Varna, Military Medical Academy, BulgariaPurpose: To adapt and validate an HPLC method for verapamil determination in blood and urine samples. Materials/Methods: Identification of verapamil and its metabolites was made by means of gas-chromatography, using Agilent 7890B/5977A GC-MS system featuring a DB-1701 column. Quantification was done by means of liquid chromatography on Agilent 1260 series HPLC, equipped with Zorbax Extend-C18 column and both diode-array and fluorescent detection modules. Blood and urine specimens were taken from patients of the Clinic for intensive treatment of acute intoxications and toxicoallergies within the course of their treatment. Results: GC-MS identification of verapamil and its metabolites was carried out after simple liquid-liquid extraction of samples without further chemical derivatization. Adapted HPLC method for quantification require isocratic conditions and mobile phase, consisted of phosphate buffer (pH 2.7; 10 mM) containing 1.5 ml L–1 triethylamine – acetonitrile (70:30, v/v) at 20oC, flow-rate 1.0 mL/min and FLD detection (excitation: 203 nm, emission: 320 nm). The method was demonstrated to be linear within the whole region of interest (4.6-4600 ng mL–1) with excellent accuracy (101.7-102.2%) and inter-day precision (5.81%) as well as good analytical recovery (81.2%) and LOQ (7.0 ng mL–1). Conclusion: A precise and easy to use method for verapamil detection and quantification is developed. The method is applicable as a routine procedure in the Laboratory of analytical toxicology for both diagnosis clarification in cases of acute intoxications and therapeutic drug monitoring.https://www.journal-imab-bg.org/issues-2020/issue4/2020vol26-issue4-3403-3407.pdfverapamilgc-mshplcacute intoxicationstherapeutic drug monitoring
spellingShingle Georgi Bonchev
Snezha Zlateva
Petko Marinov
Ivelina Stefanova
IDENTIFICATION AND QUANTIFICATION OF VERAPAMIL IN BLOOD AND URINE
Journal of IMAB
verapamil
gc-ms
hplc
acute intoxications
therapeutic drug monitoring
title IDENTIFICATION AND QUANTIFICATION OF VERAPAMIL IN BLOOD AND URINE
title_full IDENTIFICATION AND QUANTIFICATION OF VERAPAMIL IN BLOOD AND URINE
title_fullStr IDENTIFICATION AND QUANTIFICATION OF VERAPAMIL IN BLOOD AND URINE
title_full_unstemmed IDENTIFICATION AND QUANTIFICATION OF VERAPAMIL IN BLOOD AND URINE
title_short IDENTIFICATION AND QUANTIFICATION OF VERAPAMIL IN BLOOD AND URINE
title_sort identification and quantification of verapamil in blood and urine
topic verapamil
gc-ms
hplc
acute intoxications
therapeutic drug monitoring
url https://www.journal-imab-bg.org/issues-2020/issue4/2020vol26-issue4-3403-3407.pdf
work_keys_str_mv AT georgibonchev identificationandquantificationofverapamilinbloodandurine
AT snezhazlateva identificationandquantificationofverapamilinbloodandurine
AT petkomarinov identificationandquantificationofverapamilinbloodandurine
AT ivelinastefanova identificationandquantificationofverapamilinbloodandurine